Urothelial Cancer

The Gabrail Cancer Center currently has many Clinical Trial opportunities . For more information and to see if you qualify call Carrie Smith R.N., Director of Research at 330-492-3345 x 208 or email
CSmith@GabrailCancerCenter.com.

A Study of Enfortumab Vedotin(ASG-22CE) as Monotherapy or in Combination with other Anticancer Therapies for the Treatment of Urothelial Cancer

Return to Clinical Trials at GCC